Home Cart 0 Sign in  

[ CAS No. 1242156-59-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1242156-59-7
Chemical Structure| 1242156-59-7
Structure of 1242156-59-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1242156-59-7 ]

Related Doc. of [ 1242156-59-7 ]

Alternatived Products of [ 1242156-59-7 ]

Product Details of [ 1242156-59-7 ]

CAS No. :1242156-59-7 MDL No. :MFCD23099569
Formula : C12H13FN2O Boiling Point : -
Linear Structure Formula :- InChI Key :UQLKXNSVRRFDGE-UHFFFAOYSA-N
M.W : 220.24 Pubchem ID :59473765
Synonyms :

Calculated chemistry of [ 1242156-59-7 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.33
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 61.59
TPSA : 45.75 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.88 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.94
Log Po/w (XLOGP3) : 2.48
Log Po/w (WLOGP) : 2.78
Log Po/w (MLOGP) : 2.86
Log Po/w (SILICOS-IT) : 3.62
Consensus Log Po/w : 2.74

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.16
Solubility : 0.151 mg/ml ; 0.000685 mol/l
Class : Soluble
Log S (Ali) : -3.09
Solubility : 0.181 mg/ml ; 0.000821 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.73
Solubility : 0.00408 mg/ml ; 0.0000185 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.18

Safety of [ 1242156-59-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1242156-59-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1242156-59-7 ]
  • Downstream synthetic route of [ 1242156-59-7 ]

[ 1242156-59-7 ] Synthesis Path-Upstream   1~13

  • 1
  • [ 1242156-58-6 ]
  • [ 1242156-59-7 ]
YieldReaction ConditionsOperation in experiment
86% With hydrazine hydrate; acetic acid In ethanol at 80℃; for 6 h; 4-tert-Butyl-2-dimethoxymethyl-6-fluoro-benzoic acid (220.3 g, 0.815 moles) was dissolved in ethanol (2 vol, 440 mL) and acetic acid (0.5 vol, 110 mL).
Hydrazine hydrate (1.5 eq, 61 mL) was added and the solution stirred at 80° C. for 6 hours.
The mixture was cooled to rt overnight, then in an ice bath and then filtered and washed with cold ethanol.
The fine white crystals were dried at 100° C. in a vacuum oven with N2 sweep, to provide 154.7 g (86percent) of 6-tert-butyl-8-fluoro-2H-phthalazin-1-one.
Reference: [1] Patent: US2010/222325, 2010, A1, . Location in patent: Page/Page column 61
[2] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 2, p. 367 - 371
  • 2
  • [ 1433849-07-0 ]
  • [ 1242156-59-7 ]
YieldReaction ConditionsOperation in experiment
37.6% With hydrazine hydrate In acetic acid at 50℃; for 1.5 h; Inert atmosphere Example 101h
6-tert-Butyl-8-fluorophthalazin-1(2H)-one 101h
To a solution of 101g (40 g, 168 mmol) in glacial acetic acid (360 mL) was added hydrazine monohydrate (240 mL) at 0-10° C. under N2 protection.
The resulting slurry was stirred under nitrogen at 50° C. for 1.5 hours.
The reaction mixture was poured into 300 mL of water with continuous stirring.
The aqueous phase was extracted with DCM (2*500 mL), and the combined organic phase was dried over Na2SO4, filtered and concentrated to give a residue, which was purified by re-crystallization in DMC and Et2O to provide 101h (17 g, 37.6percent over 2 steps) as an off-white solid. 1HNMR (300 MHz, CDCl3) δ 8.11 (d, J=2.7 Hz, 1H), 7.46 (m, 2H), 1.39 (s, 9H). LCMS (ESI) m/z 221 (M+H)+.
Reference: [1] Patent: US2013/116246, 2013, A1, . Location in patent: Paragraph 0234; 0235
  • 3
  • [ 1242157-10-3 ]
  • [ 1242156-59-7 ]
Reference: [1] Patent: US2010/222325, 2010, A1, . Location in patent: Page/Page column 139
  • 4
  • [ 1710-98-1 ]
  • [ 1242156-59-7 ]
Reference: [1] Patent: US2013/116246, 2013, A1,
  • 5
  • [ 98-73-7 ]
  • [ 1242156-59-7 ]
Reference: [1] Patent: US2013/116246, 2013, A1,
  • 6
  • [ 438481-01-7 ]
  • [ 1242156-59-7 ]
Reference: [1] Patent: US2013/116246, 2013, A1,
  • 7
  • [ 150943-13-8 ]
  • [ 1242156-59-7 ]
Reference: [1] Patent: US2013/116246, 2013, A1,
  • 8
  • [ 1242157-07-8 ]
  • [ 1242156-59-7 ]
Reference: [1] Patent: US2013/116246, 2013, A1,
  • 9
  • [ 1242157-08-9 ]
  • [ 1242156-59-7 ]
Reference: [1] Patent: US2013/116246, 2013, A1,
  • 10
  • [ 1242157-09-0 ]
  • [ 1242156-59-7 ]
Reference: [1] Patent: US2013/116246, 2013, A1,
  • 11
  • [ 1123172-38-2 ]
  • [ 1242156-59-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 2, p. 367 - 371
  • 12
  • [ 1123172-37-1 ]
  • [ 1242156-59-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 2, p. 367 - 371
  • 13
  • [ 1242156-57-5 ]
  • [ 1242156-59-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 2, p. 367 - 371
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1242156-59-7 ]

Fluorinated Building Blocks

Chemical Structure| 23928-52-1

[ 23928-52-1 ]

7-Fluorophthalazin-1(2H)-one

Similarity: 0.86

Chemical Structure| 1021298-68-9

[ 1021298-68-9 ]

2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile

Similarity: 0.78

Chemical Structure| 763111-47-3

[ 763111-47-3 ]

4-(4-Fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one

Similarity: 0.77

Chemical Structure| 446-24-2

[ 446-24-2 ]

2-Fluorobenzohydrazide

Similarity: 0.75

Chemical Structure| 763114-26-7

[ 763114-26-7 ]

2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid

Similarity: 0.72

Amides

Chemical Structure| 23928-52-1

[ 23928-52-1 ]

7-Fluorophthalazin-1(2H)-one

Similarity: 0.86

Chemical Structure| 1021298-68-9

[ 1021298-68-9 ]

2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile

Similarity: 0.78

Chemical Structure| 763111-47-3

[ 763111-47-3 ]

4-(4-Fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one

Similarity: 0.77

Chemical Structure| 446-24-2

[ 446-24-2 ]

2-Fluorobenzohydrazide

Similarity: 0.75

Chemical Structure| 763114-26-7

[ 763114-26-7 ]

2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid

Similarity: 0.72

Related Parent Nucleus of
[ 1242156-59-7 ]

Phthalazines

Chemical Structure| 23928-52-1

[ 23928-52-1 ]

7-Fluorophthalazin-1(2H)-one

Similarity: 0.86

Chemical Structure| 1021298-68-9

[ 1021298-68-9 ]

2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile

Similarity: 0.78

Chemical Structure| 763111-47-3

[ 763111-47-3 ]

4-(4-Fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one

Similarity: 0.77

Chemical Structure| 763114-26-7

[ 763114-26-7 ]

2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid

Similarity: 0.72

Chemical Structure| 119-39-1

[ 119-39-1 ]

Phthalazin-1(2H)-one

Similarity: 0.72